首页> 外文期刊>Molecular cancer research: MCR >Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
【24h】

Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

机译:慢性髓细胞性白血病CD34 +细胞中hsa-miR-10a的下调可增加USF2介导的细胞生长。

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNA) are small noncoding, single-stranded RNAs that inhibit gene expression at a posttranscriptional level, whose abnormal expression has been described in different tumors. The aim of our study was to identify miRNAs potentially implicated in chronic myeloid leukemia (CML). We detected an abnormal miRNA expression profile in mononuclear and CD34(+) cells from patients with CML compared with healthy controls. Of 157 miRNAs tested, hsa-miR-10a, hsa-miR-150, and hsa-miR-151 were down-regulated, whereas hsa-miR-96 was up-regulated in CML cells. Down-regulation of hsa-miR-10a was not dependent on BCR-ABL1 activity and contributed to the increased cell growth of CML cells. We identified the upstream stimulatory factor 2 (USF2) as a potential target of hsa-miR-10a and showed that overexpression of USF2 also increases cell growth. The clinical relevance of these findings was shown in a group of 85 newly diagnosed patients with CML in which expression of hsa-miR-10a was down-regulated in 71% of the patients, whereas expression of USF2 was up-regulated in 60% of the CML patients, with overexpression of USF2 being significantly associated with decreased expression of hsa-miR-10a (P = 0.004). Our results indicate that down-regulation of hsa-miR-10a may increase USF2 and contribute to the increase in cell proliferation of CML implicating a miRNA in the abnormal behavior of CML.
机译:微小RNA(miRNA)是小的非编码单链RNA,可在转录后水平抑制基因表达,其异常表达已在不同的肿瘤中得到描述。我们研究的目的是鉴定可能与慢性粒细胞白血病(CML)有关的miRNA。与健康对照组相比,我们在CML患者的单核和CD34(+)细胞中检测到异常的miRNA表达谱。在测试的157个miRNA中,在CML细胞中,hsa-miR-10a,hsa-miR-150和hsa-miR-151被下调,而hsa-miR-96被上调。 hsa-miR-10a的下调不依赖于BCR-ABL1活性,并有助于增加CML细胞的细胞生长。我们确定了上游刺激因子2(USF2)作为hsa-miR-10a的潜在目标,并表明USF2的过表达也增加了细胞的生长。这些发现的临床意义显示在一组85名新诊断的CML患者中,其中71%的患者中hsa-miR-10a的表达下调,而60%的患者中USF2的表达上调。 CML患者中,USF2的过度表达与hsa-miR-10a的表达降低显着相关(P = 0.004)。我们的结果表明,hsa-miR-10a的下调可能会增加USF2,并导致CML细胞增殖的增加,从而使miRNA参与CML的异常行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号